Stay updated on Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No other content or functionality on the page was affected.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe history now includes a new entry: Revision: v3.4.2; the previously visible notice about government funding delays and the prior Revision: v3.4.1 have been removed.SummaryDifference0.3%

- Check40 days agoChange DetectedAdded a government funding lapse notice at the top directing users to cc.nih.gov and opm.gov; updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check47 days agoChange DetectedUI enhancements in the history view add a glossary display and green/red color-coded highlights to show additions and deletions. Revision notes have been updated from v3.3.4 to v3.4.0.SummaryDifference0.3%

- Check61 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedFooter updated to show Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.